BridgeBio Oncology Therapeutics, Inc. SEC EDGAR Filings (CIK 0001869105)

SEC EDGAR filings, ownership reports, and insider transactions for BridgeBio Oncology Therapeutics, Inc..

Symbol
BBOT on Nasdaq
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
256 E. Grand Avenue, Suite 104, South San Francisco, CA, 94080
State of incorporation
DE
Fiscal year end
31 December
Former names
Helix Acquisition Corp. II (to 06 Aug 2025)
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
BridgeBio Oncology Therapeutics, Inc. has filed 125 SEC EDGAR filings since 20 Dec 2023

Latest Filings

Recent SEC filings for BridgeBio Oncology Therapeutics, Inc. including 424B3, 8-K, 4 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
424B3 Open 424B3 document View SEC filing for 424B3 424B3 07 Jan 2026 333-289940
424B3 Open 424B3 document View SEC filing for 424B3 424B3 07 Jan 2026 333-289940
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 07 Jan 2026 07 Jan 2026 001-41955
4 Open 4 document View SEC filing for 4 4 05 Jan 2026 01 Jan 2026
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 02 Jan 2026 333-292555
4 Open 4 document View SEC filing for 4 4 12 Dec 2025 10 Dec 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Nov 2025 005-94447
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 13 Nov 2025 005-94447
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 Nov 2025 30 Sep 2025 001-41955
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Nov 2025 12 Nov 2025 001-41955
4 Open 4 document View SEC filing for 4 4 16 Oct 2025 10 Oct 2025
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 10 Oct 2025 333-290825
4 Open 4 document View SEC filing for 4 4 06 Oct 2025 02 Oct 2025
EFFECT Open EFFECT document View SEC filing for EFFECT 10 Sep 2025 333-289940
424B3 Open 424B3 document View SEC filing for 424B3 424B3 10 Sep 2025 333-289940
CORRESP Open CORRESP document View SEC filing for CORRESP 08 Sep 2025
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 03 Sep 2025 333-289940
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 03 Sep 2025 005-94447
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 29 Aug 2025 333-289940
4 Open 4 document View SEC filing for 4 4 28 Aug 2025 26 Aug 2025
4 Open 4 document View SEC filing for 4 4 28 Aug 2025 26 Aug 2025
4 Open 4 document View SEC filing for 4 4 28 Aug 2025 26 Aug 2025
4 Open 4 document View SEC filing for 4 4 28 Aug 2025 26 Aug 2025
4 Open 4 document View SEC filing for 4 4 28 Aug 2025 26 Aug 2025
4 Open 4 document View SEC filing for 4 4 28 Aug 2025 26 Aug 2025
4 Open 4 document View SEC filing for 4 4 28 Aug 2025 26 Aug 2025
EFFECT Open EFFECT document View SEC filing for EFFECT 19 Aug 2025 333-288222
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 18 Aug 2025 005-94447
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 18 Aug 2025 005-94447
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025
POS AM Open POS AM document | Open XBRL data View SEC filing for POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-4 15 Aug 2025 333-288222
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 13 Aug 2025 005-94447
4 Open 4 document View SEC filing for 4 13 Aug 2025 11 Aug 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 13 Aug 2025 11 Aug 2025 001-41955
3 Open 3 document View SEC filing for 3 11 Aug 2025 11 Aug 2025
4 Open 4 document View SEC filing for 4 11 Aug 2025 11 Aug 2025
4 Open 4 document View SEC filing for 4 11 Aug 2025 11 Aug 2025
4 Open 4 document View SEC filing for 4 11 Aug 2025 11 Aug 2025
4 Open 4 document View SEC filing for 4 11 Aug 2025 11 Aug 2025
4 Open 4 document View SEC filing for 4 11 Aug 2025 11 Aug 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 06 Aug 2025 06 Aug 2025 001-41955
425 Open 425 document View SEC filing for 425 CURRENT REPORT 04 Aug 2025 001-41955
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 04 Aug 2025 04 Aug 2025 001-41955
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 01 Aug 2025 30 Jun 2025 001-41955
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 30 Jul 2025 005-94447
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 24 Jul 2025 005-94447
424B3 Open 424B3 document View SEC filing for 424B3 PROSPECTUS SUPPLEMENT 22 Jul 2025 333-288222
425 Open 425 document View SEC filing for 425 FORM 425 21 Jul 2025 001-41955
425 Open 425 document View SEC filing for 425 CURRENT REPORT 11 Jul 2025 001-41955
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 11 Jul 2025 11 Jul 2025 001-41955
EFFECT Open EFFECT document View SEC filing for EFFECT 10 Jul 2025 333-288222
424B4 Open 424B4 document View SEC filing for 424B4 PROSPECTUS 10 Jul 2025 333-288222
CORRESP Open CORRESP document View SEC filing for CORRESP 09 Jul 2025
S-4/A Open S-4/A document | Open XBRL data View SEC filing for S-4/A REGISTRATION STATEMENT 09 Jul 2025 333-288222
CORRESP Open CORRESP document View SEC filing for CORRESP 01 Jul 2025
S-4/A Open S-4/A document | Open XBRL data View SEC filing for S-4/A REGISTRATION STATEMENT 01 Jul 2025 333-288222
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 27 Jun 2025 377-07895
CORRESP Open CORRESP document View SEC filing for CORRESP 20 Jun 2025
S-4 Open S-4 document | Open XBRL data View SEC filing for S-4 REGISTRATION STATEMENT 20 Jun 2025 333-288222
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 11 Jun 2025 377-07895
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 30 May 2025
DRS/A Open DRS/A document View SEC filing for DRS/A 30 May 2025 377-07895
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 15 May 2025 31 Mar 2025 001-41955
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 13 May 2025 377-07895
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 22 Apr 2025 005-94447
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 15 Apr 2025 005-94447
DRS Open DRS document View SEC filing for DRS 15 Apr 2025 377-07895
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 14 Apr 2025
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K ANNUAL REPORT 11 Mar 2025 31 Dec 2024 001-41955
425 Open 425 document View SEC filing for 425 FORM 425 06 Mar 2025 001-41955
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 04 Mar 2025 005-94447
425 Open 425 document | Open XBRL data View SEC filing for 425 CURRENT REPORT 03 Mar 2025 001-41955
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 03 Mar 2025 28 Feb 2025 001-41955
425 Open 425 document View SEC filing for 425 CURRENT REPORT 28 Feb 2025 001-41955
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 28 Feb 2025 28 Feb 2025 001-41955
3 Open 3 document View SEC filing for 3 11 Feb 2025 08 Feb 2025
4 Open 4 document View SEC filing for 4 10 Feb 2025 08 Feb 2025
4 Open 4 document View SEC filing for 4 10 Feb 2025 08 Feb 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 10 Feb 2025 08 Feb 2025 001-41955
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 14 Nov 2024 30 Sep 2024 001-41955
SC 13G Open SC 13G document View SEC filing for SC 13G 14 Nov 2024 005-94447
SC 13G Open SC 13G document View SEC filing for SC 13G 08 Nov 2024 005-94447
SC 13G Open SC 13G document View SEC filing for SC 13G 22 Oct 2024 005-94447
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 14 Aug 2024 30 Jun 2024 001-41955
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 15 May 2024 31 Mar 2024 001-41955
SC 13G Open SC 13G document View SEC filing for SC 13G HELIX ACQUISITION CORP. II 23 Feb 2024 005-94447
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 23 Feb 2024 005-94447
SC 13D Open SC 13D document View SEC filing for SC 13D SCHEDULE 13D 20 Feb 2024 005-94447
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 20 Feb 2024 13 Feb 2024 001-41955
SC 13G Open SC 13G document View SEC filing for SC 13G 15 Feb 2024 005-94447
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 14 Feb 2024 08 Feb 2024 001-41955
4 Open 4 document View SEC filing for 4 13 Feb 2024 13 Feb 2024
4 Open 4 document View SEC filing for 4 13 Feb 2024 13 Feb 2024
424B4 Open 424B4 document View SEC filing for 424B4 PROSPECTUS 13 Feb 2024 333-276591
3 Open 3 document View SEC filing for 3 09 Feb 2024 08 Feb 2024
3 Open 3 document View SEC filing for 3 09 Feb 2024 08 Feb 2024
3 Open 3 document View SEC filing for 3 09 Feb 2024 08 Feb 2024
EFFECT Open EFFECT document View SEC filing for EFFECT 08 Feb 2024 333-276591
S-1MEF Open S-1MEF document View SEC filing for S-1MEF REGISTRATION STATEMENT 08 Feb 2024 333-276958
3 Open 3 document View SEC filing for 3 08 Feb 2024 08 Feb 2024
3 Open 3 document View SEC filing for 3 08 Feb 2024 08 Feb 2024
3 Open 3 document View SEC filing for 3 08 Feb 2024 08 Feb 2024
CERT Open CERT document View SEC filing for CERT 08 Feb 2024 001-41955
8-A12B Open 8-A12B document View SEC filing for 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 08 Feb 2024 001-41955
CORRESP Open CORRESP document View SEC filing for CORRESP 07 Feb 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 07 Feb 2024
S-1/A Open S-1/A document View SEC filing for S-1/A REGISTRATION STATEMENT 07 Feb 2024 333-276591
CORRESP Open CORRESP document View SEC filing for CORRESP 06 Feb 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 06 Feb 2024 377-07010
CORRESP Open CORRESP document View SEC filing for CORRESP 02 Feb 2024
S-1/A Open S-1/A document View SEC filing for S-1/A REGISTRATION STATEMENT 02 Feb 2024 333-276591
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 23 Jan 2024 377-07010
CORRESP Open CORRESP document View SEC filing for CORRESP 18 Jan 2024
S-1 Open S-1 document View SEC filing for S-1 REGISTRATION STATEMENT 18 Jan 2024 333-276591
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 10 Jan 2024 377-07010
DRS Open DRS document View SEC filing for DRS 20 Dec 2023 377-07010

About this filer

BridgeBio Oncology Therapeutics, Inc. files with the SEC under CIK 0001869105. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages